In this podcast, Robert Burkes, MD, answers our questions about his team's latest study on the relationship between 25-hydroxyvitamin D (25-OH-vitamin D) and chronic obstructive pulmonary disease (COPD)...
In this podcast, Chandler Howell, PharmD, speaks about the guideline-recommended first and second-line treatment options for type 2 diabetes, the pharmacist involvement in the care of people with diabetes,...
In this podcast, Chandler Howell, PharmD, speaks about the guideline-recommended first and second-line treatment options for type 2 diabetes, the pharmacist involvement in the care of people with diabetes,...
In this podcast, Chandler Howell, PharmD, speaks about the guideline-recommended first and second-line treatment options for type 2 diabetes, the pharmacist involvement in the care of people with diabetes,...
In this podcast, Senior Physician Assistant, Steven Wurzelbacher, PA-C, discusses his approach to bleeding management in his Orthopedic Joint procedures.
In this podcast, Thomas Keller, MD, discusses his analysis on the association of guideline-recommended chronic obstructive pulmonary disease inhaler regimens with mortality, respiratory exacerbations, and...
In this podcast, Thomas Keller, MD, discusses his analysis on the association of guideline-recommended chronic obstructive pulmonary disease inhaler regimens with mortality, respiratory exacerbations, and...
In this podcast, Thomas Keller, MD, discusses his analysis on the association of guideline-recommended chronic obstructive pulmonary disease inhaler regimens with mortality, respiratory exacerbations, and...
Peter H. Jones, MD, discussed identifying high-risk patients and targeting specific lipid therapy to reduce risk of future cardiovascular disease events.
Peter H. Jones, MD, discussed identifying high-risk patients and targeting specific lipid therapy to reduce risk of future cardiovascular disease events.
